In the context of other tumor types, a case study of a primary cutaneous T cell lymphoma showed a temporary remission after a combination therapy with rituximab and chemotherapy, associated with decrease in Tregs and increase in CD8+ T cells.110. This evidence concerns the gene CD8A and neoplasm.